Johnson & Johnson announced on Monday it was pausing clinical trials of a COVID-19 vaccine candidate due to an unexplained illness in a study participant. The delay weighed on the company's shares, even after its beat-and-raise earnings report. Its shares lost 2.3%.from Stocks-Markets-Economic Times https://ift.tt/314f71Y
0 Comments:
Post a Comment